Pfizer and BioNTech say updated COVID-19 boosters show increased immune response against Omicron
Two Pfizer and BioNTech COVID-19 vaccine boosters updated to target the Omicron variant show a substantially higher immune response than the current COVID-19 vaccine, the companies said Saturday.